about
A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in AustraliaThe Sydney playground project--levelling the playing field: a cluster trial of a primary school-based intervention aiming to promote manageable risk-taking in children with disabilityInternational perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions.How far does screening women for domestic (partner) violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK National Screening Committee criteria.BMI is Associated with the Willingness to Record Diet with a Mobile Food Record among Adults Participating in Dietary Interventions.A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments.Increase in computed tomography in Australia driven mainly by practice change: A decomposition analysis.Challenges and opportunities for disinvestment in Australia.Challenges in the health economics of familial hypercholesterolemia.Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.Understanding the costs of care for cystic fibrosis: an analysis by age and health state.Time trade-off derived EQ-5D weights for Australia.The Impact of Different DCE-Based Approaches When Anchoring Utility Scores.QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study.Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis.Introduction and uptake of new medical technologies in the Australian health care system: a qualitative study.An Australian discrete choice experiment to value eq-5d health states.A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task.Cost-effectiveness of carrier screening for cystic fibrosis in Australia.Australian health-related quality of life population norms derived from the SF-6D.The impact of interpretive and reductive front-of-pack labels on food choice and willingness to pay.How Should DCE with Duration Choice Sets Be Presented for the Valuation of Health States?Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.Estimating health state utility values from discrete choice experiments--a QALY space model approach.The desire and capability of Australian general practitioners to change their working hours.Valuing SF-6D Health States Using a Discrete Choice Experiment.A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.Lessons from Albion: Can Australia learn from England's approach to primary healthcare funding?Can hospital-based doctors change their working hours? Evidence from Australia.Cost-effectiveness of an advance notification letter to increase colorectal cancer screening.Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health StatesA randomized trial assessing the effects of health claims on choice of foods in the presence of front-of-pack labelsSymptoms and feelings valued by patients after a percutaneous coronary intervention: a discrete-choice experiment to inform development of a new patient-reported outcomeParent-child genetic testing for familial hypercholesterolaemia in an Australian context
P50
Q34417226-EB086F93-8884-4450-89E4-6E9B5243DD7BQ35842803-4A041168-6EF4-47E0-9805-CF93EB72209FQ37281696-A29AC47D-8903-47E1-AB6D-1C4E4859B5B1Q37409580-BA287D49-265F-4B29-8C77-AF5455C14C54Q37729739-141F1AB0-4120-4D6D-AAB1-9E74B89F664BQ38560401-20C12A97-A4FC-412A-99A1-0BE8AEEC96F1Q38760347-66465EF1-4871-4CF1-A818-5F95D836FFE2Q38796496-621197E3-4720-4BB9-8690-AB56EF5627E9Q38995326-75DAB65E-5809-49DE-B3EC-8DEBB491A1F7Q39092825-D9B8513F-1BF4-4DD5-83A0-F6A6A2069CB3Q39165629-1CF30630-8372-4095-B5C0-0972893AAFD6Q39315504-8169BE40-A762-4728-B591-EEC3F2FF72FAQ39443568-39E9F5ED-5BB3-4A83-B165-067A95687707Q39708036-E417B87E-DCF0-460C-8713-0F10172DA6F3Q39872768-D7FEE301-8DB9-4B6D-8AFC-67C809788228Q40083161-F8A77AC8-605C-434F-A35A-CF1F960B99C9Q40251610-1ACC2283-6E07-4C20-BE9F-DB9FE49410B4Q40569987-DBFA0912-A916-4F75-A547-190CAD1715ACQ41085106-FF1D300C-7174-445E-BA7D-D4BA437CBCDBQ41673679-C66AEA23-8683-4A59-826D-FA51E5FE6778Q43409106-26F131BF-1CCC-4FD0-8A71-96F32719FBAEQ43891957-D7C55F57-1D4C-4453-ACF3-FFBB6863465DQ44188764-14F8CD87-7FF9-4FE9-9B08-1BD9DA99F218Q44393418-D64BBE46-3669-4473-962A-1CEF2C9863B3Q44607917-99CB393D-711C-4D22-AA1C-A0B6F2793EC1Q46801683-E0718E50-94EB-4A27-9D68-81E4D8344CB0Q47140685-E866FE90-3C5F-4AA3-8966-195B54F26166Q47690105-88AB9528-E2CA-4B9E-B78D-149C817EF0F3Q48068074-BAD67223-A782-48B8-A510-A205406A70C5Q48072882-79CE2B65-C937-4A1A-8650-913E7FD0D2F2Q48077544-BE6805E7-1FFA-44B5-BF8D-CFCC0475601FQ48171221-366D44A8-2F6D-49BC-94C3-1FF90C82FAE7Q48217306-40F186E7-3AA7-4917-8BB8-EA614B63C182Q50550102-C6243A1B-0FEC-4D07-A337-38E71D4E0158Q51155369-D35DC257-6FC2-4733-BE1A-FCF8575FA86FQ51803705-89AFB2C8-88E6-4793-8402-89B6A6216763Q57173796-1321A207-13AB-485E-8DC1-59E6A0A69FDFQ57800570-8A1E3ECD-C105-4724-80B5-1A06F7FF2958Q57812048-08D65705-45C7-4130-82B3-2ADB1D2DB82FQ58008137-1E9727CC-B570-4D18-9DE9-7D51B41CC46C
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Richard Norman
@ast
Richard Norman
@de
Richard Norman
@en
Richard Norman
@es
Richard Norman
@nl
Richard Norman
@sl
type
label
Richard Norman
@ast
Richard Norman
@de
Richard Norman
@en
Richard Norman
@es
Richard Norman
@nl
Richard Norman
@sl
prefLabel
Richard Norman
@ast
Richard Norman
@de
Richard Norman
@en
Richard Norman
@es
Richard Norman
@nl
Richard Norman
@sl
P108
P214
P227
P106
P21
P214
P227
1035445913
P31
P496
0000-0002-3112-3893
P734
P735
P7859
viaf-300810286